Global and United States Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Intravenous
1.2.3 Intracerebroventricular
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application: 2020 VS 2026
1.3.2 Relapsing-Remitting Multiple Sclerosis (RRMS)
1.3.3 Primary Progressive Multiple Sclerosis (PPMS)
1.3.4 Secondary Progressive Multiple Sclerosis (SPMS)
1.3.5 Progressive Relapsing Multiple Sclerosis (PRMS)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Perspective (2015-2026)
2.2 Global Stem Cell Therapy for Multiple Sclerosis Growth Trends by Regions
2.2.1 Stem Cell Therapy for Multiple Sclerosis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Stem Cell Therapy for Multiple Sclerosis Historic Market Share by Regions (2015-2020)
2.2.3 Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Market Size
3.1.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue (2015-2020)
3.1.2 Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Players (2015-2020)
3.2 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy for Multiple Sclerosis Revenue
3.4 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Multiple Sclerosis Revenue in 2019
3.5 Key Players Stem Cell Therapy for Multiple Sclerosis Area Served
3.6 Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy for Multiple Sclerosis Breakdown Data by Type (2015-2026)
4.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Type (2015-2020)
4.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2021-2026)
5 Stem Cell Therapy for Multiple Sclerosis Breakdown Data by Application (2015-2026)
5.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Application (2015-2020)
5.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2026)
6.2 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
6.3 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
6.4 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2026)
7.2 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
7.3 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
7.4 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2026)
8.2 China Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
8.3 China Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
8.4 China Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2026)
9.2 Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
9.3 Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
9.4 Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2026)
10.2 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
10.3 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
10.4 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 American CryoStem
11.1.1 American CryoStem Company Details
11.1.2 American CryoStem Business Overview
11.1.3 American CryoStem Stem Cell Therapy for Multiple Sclerosis Introduction
11.1.4 American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020))
11.1.5 American CryoStem Recent Development
11.2 Athersys
11.2.1 Athersys Company Details
11.2.2 Athersys Business Overview
11.2.3 Athersys Stem Cell Therapy for Multiple Sclerosis Introduction
11.2.4 Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
11.2.5 Athersys Recent Development
11.3 Celgene Cellular Therapeutics
11.3.1 Celgene Cellular Therapeutics Company Details
11.3.2 Celgene Cellular Therapeutics Business Overview
11.3.3 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Introduction
11.3.4 Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
11.3.5 Celgene Cellular Therapeutics Recent Development
11.4 Cell Cure Neurosciences
11.4.1 Cell Cure Neurosciences Company Details
11.4.2 Cell Cure Neurosciences Business Overview
11.4.3 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Introduction
11.4.4 Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
11.4.5 Cell Cure Neurosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Intravenous
Table 4. Key Players of Intracerebroventricular
Table 5. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2015-2020)
Table 9. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2021-2026)
Table 11. Stem Cell Therapy for Multiple Sclerosis Market Market Trends
Table 12. Stem Cell Therapy for Multiple Sclerosis Market Drivers
Table 13. Stem Cell Therapy for Multiple Sclerosis Market Challenges
Table 14. Stem Cell Therapy for Multiple Sclerosis Market Restraints
Table 15. Global Stem Cell Therapy for Multiple Sclerosis Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players (2015-2020)
Table 17. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2019)
Table 18. Global Stem Cell Therapy for Multiple Sclerosis by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Type (2015-2020)
Table 24. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2021-2026)
Table 25. Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Application (2015-2020)
Table 26. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Application (2021-2026)
Table 28. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 30. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 32. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2015-2020)
Table 34. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 36. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 38. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2015-2020)
Table 40. China Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (US$ Million)
Table 41. China Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 42. China Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (US$ Million)
Table 43. China Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 44. China Stem Cell Therapy for Multiple Sclerosis Market Size by Region (US$ Million) (2015-2020)
Table 45. China Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2015-2020)
Table 46. Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 48. Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 50. Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2015-2020)
Table 52. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 54. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 56. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2015-2020)
Table 58. American CryoStem Company Details
Table 59. American CryoStem Business Overview
Table 60. American CryoStem Product
Table 61. American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020) (US$ Million)
Table 62. American CryoStem Recent Development
Table 63. Athersys Company Details
Table 64. Athersys Business Overview
Table 65. Athersys Product
Table 66. Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020) (US$ Million)
Table 67. Athersys Recent Development
Table 68. Celgene Cellular Therapeutics Company Details
Table 69. Celgene Cellular Therapeutics Business Overview
Table 70. Celgene Cellular Therapeutics Product
Table 71. Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020) (US$ Million)
Table 72. Celgene Cellular Therapeutics Recent Development
Table 73. Cell Cure Neurosciences Company Details
Table 74. Cell Cure Neurosciences Business Overview
Table 75. Cell Cure Neurosciences Product
Table 76. Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020) (US$ Million)
Table 77. Cell Cure Neurosciences Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Features
Figure 3. Intracerebroventricular Features
Figure 4. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application: 2020 VS 2026
Figure 5. Relapsing-Remitting Multiple Sclerosis (RRMS) Case Studies
Figure 6. Primary Progressive Multiple Sclerosis (PPMS) Case Studies
Figure 7. Secondary Progressive Multiple Sclerosis (SPMS) Case Studies
Figure 8. Progressive Relapsing Multiple Sclerosis (PRMS) Case Studies
Figure 9. Stem Cell Therapy for Multiple Sclerosis Report Years Considered
Figure 10. Global Stem Cell Therapy for Multiple Sclerosis Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions: 2020 VS 2026
Figure 12. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2021-2026)
Figure 13. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players in 2019
Figure 14. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue in 2019
Figure 16. North America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. American CryoStem Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
Figure 44. Athersys Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
Figure 45. Celgene Cellular Therapeutics Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
Figure 46. Cell Cure Neurosciences Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed